New indications for exenatide therapy of type 2 diabetes mellitus
Obesity associated with the enhanced risk of cardiovascular disorders plays a key role in the evolvement and progression of type 2 diabetes mellitus(DM2). Incretin mimetics are the sole class of hypoglycemic agents that not only effectively correct hyperglycemia but also reduce body weight. Exenatid...
Saved in:
Main Authors: | Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/966c47654fdf45d8a1986ff7d62d681c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011) -
Ion- and osmoregulating renal functions in patients with type 2 diabetes mellitus
by: Evgeniya Vladimirovna Balbotkina, et al.
Published: (2016) -
New prospects in the treatment of diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012) -
Glibenclamide therapy: pros and cons
by: Olga Konstantinovna Vikulova, et al.
Published: (2011) -
Inсretin-based therapy in patients with type 2 diabetes and chronic kidney disease
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012)